Implications of the ESMO study findings on oncology pharmacy

Date 28 September 2014
Event ESMO 2014
Session Availability of anti-neoplastic medicines across Europe: First results of the ESMO-led European Consortium Study
Topics Bioethics, Legal, and Economic Issues
Presenter Marika Saar
Authors M. Saar
  • Clinical Pharmacist, Tartu University Hospital, - - Tartu/EE